Diagnostic Center | September 11, 2024
Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast
ALS patients experience neuroinflammation and rapid neurodegeneration
ALS patients experience neuroinflammation and rapid neurodegeneration
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Olverembatinib, a novel drug developed by Ascentage Pharma with support from the National Major New Drug Development program
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Sanofi will leverage this partnership to provide access to proprietary data to develop AI models
Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform to further power its clinical data platform
Commercial terms include research funding and milestones and/or royalty payments to Evotec based on the success of the program
Subscribe To Our Newsletter & Stay Updated
